GENE THERAPY FOR TRANSPLANTATION AND INFLAMMATORY OR THROMBOTIC CONDITIONS - Patent 0781333

(19)

(11)

EP 0 781 333 A1

(12)

(43)	Date of publication:
	02.07.1997 Bulletin 1997/27

(21)	Application number: 95931935.0

(22)	Date of filing: 25.08.1995

(51)

International Patent Classification (IPC):

A01K 67/ 027^{( . )}
A61K 38/ 00^{( . )}
A61K 48/ 00^{( . )}
C07K 14/ 745^{( . )}
C12N 5/ 10^{( . )}
C12N 15/ 09^{( . )}
C12N 15/ 85^{( . )}
C12R 1/ 91^{( . )}

A61K 35/ 36^{( . )}
A61K 38/ 36^{( . )}
A61P 7/ 02^{( . )}
C12N 5/ 00^{( . )}
C12N 7/ 00^{( . )}
C12N 15/ 12^{( . )}
C12P 21/ 02^{( . )}

(86)	International application number:
	PCT/EP1995/003379

(87)	International publication number:
	WO 1996/006933 (07.03.1996 Gazette 1996/11)

(84)	Designated Contracting States:
	AT BE CH DE DK ES FR GB GR IE IT LI LU NL PT SE
	Designated Extension States:
	SI

(30)

Priority:

26.08.1994 US 19940296945

(71)	Applicants:
	Novartis AG (Novartis SA) (Novartis Inc.) 4058 Basel (CH) Beth Israel Deaconess Medical Center Boston, MA 02215 (US)

(72)	Inventors:
	BACH, Fritz, H. Boston, MA 01966 (US) WRIGHTON, Christopher Brookline, MA 02146 (US)

(74)	Representative: Bastian, Werner Maria, et al
	Novartis AG Geistiges Eigentum Konzern Patent- und Markenabteilung CH Postfach 4002 Basel 4002 Basel (CH)

(54)	GENE THERAPY FOR TRANSPLANTATION AND INFLAMMATORY OR THROMBOTIC CONDITIONS